COVID-19 in hospitalized infants aged under 3 months: multi-center experiences across Turkey

Gülnihan Üstündağ1, Eda Karadag-Oncel2, Nursel Kara-Ulu3

  • 1Izmir Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, Health Sciences University, Izmir, Turkey.

PubMed

Insights

COVID-19 in infants under three months often presents with fever and cough. Healthy infants typically experience mild illness, while those with underlying conditions may require respiratory support and longer hospital stays.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Limited literature exists on COVID-19 in infants aged 0-3 months.
  • COVID-19 in infants and children generally presents more mildly than in adults.
  • Fever and cough are common COVID-19 symptoms in infants, similar to older age groups.

Purpose of the Study:

  • To investigate the clinical presentation and characteristics of COVID-19 in infants aged 0-3 months.
  • To identify common symptoms, bacterial co-infections, and clinical outcomes in this pediatric population.
  • To address the significant gap in scientific literature regarding infant COVID-19 cases.

Main Methods:

  • A cross-sectional study involving 570 infants across 19 medical centers in Turkey.
  • Data collection included patient demographics, symptoms, laboratory results (blood and urine cultures), and clinical course.
  • Analysis focused on comparing outcomes between infants with and without underlying conditions.

Main Results:

  • Fever (78.2%), cough (44.6%), and feeding intolerance (39.9%) were the most common symptoms.
  • Blood cultures were positive in 0.9% and urine cultures in 10.2% of infants.
  • Infants with underlying conditions showed higher rates of respiratory support needs, abnormal chest radiography, and longer hospital stays compared to healthy infants.

Conclusions:

  • COVID-19 in infants under three months can present with fever, but healthy infants often have an uneventful clinical course.
  • Infants with underlying conditions face a higher risk of respiratory complications and prolonged hospitalization.
  • Findings provide valuable clinical insights for managing COVID-19 in young infants due to limited existing evidence.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...